EUVIMEDEUVIMED entdecken
Open Access

Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMO

Andrew P Platt iD, Viviane Callier iD, Alison Grazioli, Zonghui Hu, Sydney R Stein, Megan G Anders, Seth Warner iD, Emily Ricotta iD, Trevor M Stantliff iD, Jocelyn Wu, Nicole Hays, Katherine Raja iD und 26 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Andrew P Platt und 37 weiteren Autor:innen. Beteiligte Einrichtung: Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, Biomarkers, Thrombosis. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH, NIH Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Critical illness in COVID-19 may require support with Extracorporeal Membrane Oxygenation (ECMO). As immunothrombosis contributes to pathogenesis of critical illness we quantified immunothrombotic markers in patients with COVID-19 on ECMO and evaluated the predictive capacity of these markers for death.

Methods

We performed a retrospective analysis of 74 consecutive patients with COVID-19 on ECMO at a single academic medical center between March 2020 and February 2021. SARS-CoV-2 nucleocapsid RNA and 16 immunothrombotic biomarkers were longitudinally quantified. Biomarker trajectories were assessed with univariate and multivariate models and used to predict death and decannulation across multiple models.

Results

Male sex, smoking status, high serum bilirubin level, and low partial pressure of oxygen in arterial blood to the fraction of inspired oxygen (P/F) ratio were associated with an increased risk of death. Plasma levels of 10 immunothrombotic markers were significantly elevated in fatal cases. Elevated IL-8 and von Willebrand factor (VWF) were associated with an increased hazard of death and elevated angiopoietin-2, IL-1β, IL-6, IL-8, IL-18, ICAM, p-selectin, syndecan-1, and VWF were associated with a decreased hazard for decannulation when adjusting for sex, smoking status, and time to cannulation. Predictive models incorporating biomarkers were superior to demographics alone and equivalent to models including clinical information.

Conclusions

We found increased immunothrombotic markers, male sex, and history of smoking were risk factors in patients with COVID-19 on ECMO who died as compared to those who were decannulated. These findings are important for understanding the pathogenesis of severe COVID-19 and prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19BiomarkersThrombosisHumansMaleRetrospective StudiesFemaleMiddle AgedRisk FactorsSARS-CoV-2Adult

Stichwörter der Autor:innen

COVID-19ECMObiomarkersimmunothrombosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Critical Care Medicine and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Laboratory of Virology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
  • Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Rockville, Maryland, USA.
  • R Adams Cowley Shock Trauma Center, Department of Medicine and Program in Trauma, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Biostatistics Research Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rockville, Maryland, USA.

ORCID-Profile: Andrew P Platt, Viviane Callier, Seth Warner, Emily Ricotta, Trevor M Stantliff, Katherine Raja, Madeleine Purcell, Sabrina C Ramelli, Marcos J Ramos-Benitez, Peter Rock, Ali Tabatabai, Michael T McCurdy, Daniel Herr, Kapil Saharia, Joseph Rabin, Daniel S Chertow

Förderung

  • NCI NIH HHS
  • NIH
  • NIH Clinical Center

Zitieren

APA

Platt, A. P., Callier, V., Grazioli, A., Hu, Z., Stein, S. R., Anders, M. G., Warner, S., Ricotta, E., Stantliff, T. M., Wu, J., Hays, N., Raja, K., Curto, R., Purcell, M., Singireddy, S., Tran, D., Rector, R., Cho, S., Wagner, K., …, & Chertow, D. S. (2026). Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMO. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag106

Vancouver

Platt AP, Callier V, Grazioli A, Hu Z, Stein SR, Anders MG, et al. Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMO. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag106

BibTeX
@article{Platt2026,
  author = {Platt, Andrew P and Callier, Viviane and Grazioli, Alison and Hu, Zonghui and Stein, Sydney R and Anders, Megan G and Warner, Seth and Ricotta, Emily and Stantliff, Trevor M and Wu, Jocelyn and Hays, Nicole and Raja, Katherine and Curto, Ryan and Purcell, Madeleine and Singireddy, Shreya and Tran, Douglas and Rector, Raymond and Cho, Sabrina and Wagner, Katelyn and Ramelli, Sabrina C and Ramos-Benitez, Marcos J and Dickey, James and Strich, Jeffrey R and Vannella, Kevin M and Gibbons, Miranda and Rock, Peter and Tabatabai, Ali and McCurdy, Michael T and Scalea, Thomas and Christenson, Robert and Sajadi, Mohammad M and Herr, Daniel and Taylor, Bradley and Saharia, Kapil and Madathil, Ronson J and Rabin, Joseph and Follmann, Dean and Chertow, Daniel S},
  title = {Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMO},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag106}
}
Kostenlos starten →